You have 9 free searches left this month | to do more

NIS793

NIS793 is a drug used to treat Metastatic Pancreatic Ductal Adenocarcinoma, Myelofibrosis, Breast Cancer, and other conditions. NIS793 is being actively studied in 5 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsNovartis Investigative Site
Beth Israel Deaconess Medical Cente
Emory University School of Medicine/Winship Cancer Institute
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Metastatic Colorectal Cancer
  • NIS793
  • +4 more
  • Brno, Czech Republic, Czechia
  • +8 more
2022-02-22
Feb 22, 2022
N
Completed
  • Breast Cancer
  • +5 more
  • Nashville, Tennessee
  • +11 more
2022-01-28
Jan 28, 2022
N
Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • NIS793
  • +3 more
  • Fayetteville, Arkansas
  • +16 more
2022-02-01
Feb 1, 2022
N
Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
2021-03-02
Mar 2, 2021
N
Recruiting
  • Myelodysplastic Syndromes
  • Columbus, Ohio
  • +8 more
2022-02-21
Feb 21, 2022
N
Recruiting
  • Myelofibrosis
  • Adelaide, South Australia, Australia
  • +33 more
2022-01-31
Jan 31, 2022